First Mercantile Trust’s AstraZeneca AZN Stock Holding History

First Mercantile Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-943	Closed	-$61K	–	1188
2014 Q1	$61K	Buy	+943	New	+$60.9K	﹤0.01%	1007

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

First Mercantile Trust's AZN Position: Q2 2014 in Review

First Mercantile Trust sold out of AstraZeneca (AZN) in Q2 2014, closing a stake of 943 shares — an estimated $61K sold.

First Mercantile Trust first reported a position in AZN in Q1 2014 and held it in 1 quarter. The position peaked at $61K in Q1 2014. 419 funds tracked by Wall St. Rank hold AZN as of Q2 2014.

First Mercantile Trust reported no remaining AstraZeneca position as of Q2 2014 after selling out during the quarter.
First Mercantile Trust sold 943 AstraZeneca shares in Q2 2014, an estimated $61K.
First Mercantile Trust first reported a position in AstraZeneca in Q1 2014 and held it in 1 quarter.
First Mercantile Trust's AstraZeneca position peaked at $61K in Q1 2014.
419 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2014.

Based on First Mercantile Trust's 13F filing for Q2 2014, filed 22 Jul 2014.